Indian cancer scientist develops software for patients

It will predict survival of patients with aggressive brain tumours and help provide personalised therapy.

December 24, 2015 11:44 am | Updated November 11, 2016 05:51 am IST - WASHINGTON:

An Indian scientist in the United States has developed a new MRI-based technique to predict survival of patients with aggressive brain tumours and help provide personalised therapy.

Dr. Pallavi Tiwari’s work is based on recent clinical findings that 90 per cent of the Glioblastoma Multiforme (GBM) recurrences occur close to the tumour margin, suggesting that malignant cells are present at the periphery of the tumour but are not visually discernible.

It begins with the brain

GBM is the most common and most aggressive cancer that begins within the brain.

“Less than five per cent of all GBM patients live for more than five years,” Dr. Tiwari, a leading cancer researcher working at Case Western Reserve University, said.

She said that despite several advances in drug discovery and clinical trials for cancer treatment, all GBM patients still follow the same ‘one-fits-all’ treatment regimen.

Hails from Madhya Pradesh

Dr. Tiwari, who is from Madhya Pradesh, presented her new research before at the Radiological Society of North America (RSNA) meeting recently.

“With Obama administration’s push for personalised therapy, a pressing need in precision medicine is to identify patients with GBM who are suitable for specific clinical trials based on their tumour characterisation, instead of a ’one-size-fits-all’ treatment,” a media release said.

Unfortunately, this has not been feasible so far in the absence of reliable non-invasive and quantitative measurements regarding patient prognosis (likely outcome of the disease) in GBMs, Dr. Tiwari noted.

Dr. Tiwari and her team have shown on 62 patients that these computer-extracted features from tumour margins and its surrounding areas on MRI are together predictive of GBM outcomes, the press release has said.

So far such an approach of investigating imaging features from normal-appearing areas outside of tumour margins has not been investigated.

Gleaning subtle information

Using computer techniques developed by Dr. Tiwari and her team, subtle information can be gleaned from normal-appearing regions (at tumour periphery) to allow for the ability to reliably and non-invasively stratify patients based on their survival and can ultimately guide personalised therapeutic clinical trials in GBM.

Dr. Tiwari graduated from SGSITS in Indore and moved to the United States to get a PhD degree in Biomedical Engineering.

She is currently a research assistant professor in Biomedical Engineering and since 2012 has been working in early diagnosis, prognosis, and treatment evaluation of brain tumours.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.